Lord’s Mark Industries Ltd. Acquires Renalyx, Paving the Way for the Next Era of Smart Dialysis Technology

Lord’s Mark Industries Ltd., a diversified group focused on healthcare and technology, has announced the acquisition of an 85% stake in Renalyx Health Systems Private Limited. Renalyx, based in Bengaluru, is the med-tech company behind India’s first fully indigenous smart hemodialysis machine equipped with AI capabilities and cloud connectivity. Following the acquisition, Renalyx will function as the dedicated R&D division of Lord’s Mark Industries, driving innovation in kidney- and liver-related medical technologies.

This strategic move strengthens Lord’s Mark Industries’ presence in advanced medical technology at a time when India is witnessing a rising incidence of chronic kidney disease (CKD). Renalyx’s cutting-edge dialysis system offers intelligent analytics, real-time remote monitoring, and seamless cloud integration—features that enhance safety, reliability, and cost-efficiency for dialysis centres, hospitals, and clinicians.

By integrating Renalyx into its healthcare portfolio, Lord’s Mark Industries is positioned to scale up indigenous dialysis solutions, improve patient outcomes, and expand access to high-quality renal care across urban and semi-urban regions, including Tier 1 to Tier 3 cities.

Speaking on the acquisition, Sachidanand Upadhyay, Managing Director of Lord’s Mark Industries Ltd., shared: “Our investment in Renalyx reflects our belief in the future of Indian healthcare—one driven by innovation built in India for both domestic and global markets. Dialysis services need to evolve from high-cost, infrastructure-dependent systems to smart, connected, patient-focused solutions. Renalyx joining our group accelerates this transformation. We aim to democratise advanced renal care, boost Make in India innovation, and deliver medical technologies that set new benchmarks for accessibility and clinical excellence.”

Renalyx will retain its existing engineering and product teams while benefiting from Lord’s Mark Industries’ nationwide distribution channels, diagnostics network, and manufacturing strengths to facilitate rapid market reach and adoption of its technologies.

Founded in 1998, Lord’s Mark Industries Ltd. has grown into a prominent player in the healthcare and diagnostics sector, continuously expanding its presence across the healthcare value chain with a strong emphasis on innovation and patient-centric solutions.

For more information, visit: www.renalyx.com

Moneycontrol Journalists are not involved in creation of this article.